Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Ischemic heart disease including myocardial infarction and chronic ischemia could potentially benefit from the peptide's cardioprotective effects, enhanced coronary angiogenesis, and anti-arrhythmic properties demonstrated in animal models
TB-500 (Thymosin Beta-4) Phase I and Phase II safety trials of intravenous thymosin beta-4 published in human cohorts (Ruff et al., 2010)
For active B12 deficiency, most clinicians recommend weekly or biweekly shots for the first 4 to 6 weeks, then a maintenance shot every 1 to 3 months
Drug interactions with GLP-1 agonists are relatively uncommon, but the slowed gastric emptying can affect absorption rates of oral medications taken at the same time
In a 23-week trial, subjects taking 1mg daily lost an average of 2.8kg compared to 0.8kg for placebo
US$ 22.55
US$ 21.60
US$ 29.08
US$ 21.87
